Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer

Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer

Immunotherapies, especially the programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors, have revolutionized the therapeutic strategies of various cancers. As for colorectal cancer (CRC), the current clinical application of PD-1/PD-L1 inhibitors are mainly used according to th...

Full description

Bibliographic Details
Main Authors: Zhengyang Yang, Guocong Wu, Xiao Zhang, Jiale Gao, Cong Meng, Yishan Liu, Qi Wei, Liting Sun, Pengyu Wei, Zhigang Bai, Hongwei Yao, Zhongtao Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
colorectal cancer
PD-1/PD-L1 inhibitors
neoadjuvant
microsatellite instability
mismatch repair
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001444/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1001444/full

Similar Items